Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Nam, Han-Kyul | - |
dc.contributor.author | Jeong, So-Ra | - |
dc.contributor.author | Pyo, Min Cheol | - |
dc.contributor.author | Ha, Sang-Keun | - |
dc.contributor.author | Nam, Mi-Hyun | - |
dc.contributor.author | Lee, Kwang-Won | - |
dc.date.accessioned | 2022-02-16T01:43:00Z | - |
dc.date.available | 2022-02-16T01:43:00Z | - |
dc.date.created | 2022-01-20 | - |
dc.date.issued | 2021-11 | - |
dc.identifier.issn | 0918-6158 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/135929 | - |
dc.description.abstract | Advanced glycation end products (AGEs) are the products formed through a non-enzymatic reaction of reducing sugars with proteins or lipids. There is a potential for toxicity in the case of AGEs produced through glycation with dicarbonyl compounds including methylglyoxal, glyoxal, and 3-deoxyglucosone. The AGEs bind the receptor for advanced glycation end products (RAGE) and stimulate the mitogen-activated protein (MAP) kinase signaling pathway that can increase the production of matrix metalloproteinases (MMPs). In addition, AGE-induced protein kinase B (Akt) signaling can promote cancer cell proliferation and contribute to many diseases such as kidney cancer. In light of the lack of extensive study of the relationship between methylglyoxal-induced AGEs (AGE4) and renal cancer, we studied the proliferous and anti-apoptotic effects of AGE4 on renal cell carcinoma (RCC) in this study. AGE4 treatment was involved in the proliferation and migration of RCC cells in vitro by upregulating proliferating cell nuclear antigen (PCNA) and MMPs while suppressing apoptotic markers such as Bax and caspase 3. Moreover, Akt and extracellular-signal-regulated kinase (ERK) were phosphorylated in RCC cells with AGE4 treatment. As a result, this study demonstrated that AGE4-RAGE axis can promote the growth ability of RCC by inducing PCNA, MMPs, and inhibiting apoptosis in RCC via the Akt and ERK signaling pathways. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | PHARMACEUTICAL SOC JAPAN | - |
dc.subject | APOPTOSIS | - |
dc.subject | CANCER | - |
dc.subject | EXPRESSION | - |
dc.subject | MIGRATION | - |
dc.subject | ERK | - |
dc.subject | AUTOPHAGY | - |
dc.subject | RAGE | - |
dc.subject | INFLAMMATION | - |
dc.subject | ENDPRODUCTS | - |
dc.subject | MECHANISMS | - |
dc.title | Methylglyoxal-Derived Advanced Glycation End Products (AGE4) Promote Cell Proliferation and Survival in Renal Cell Carcinoma Cells through the RAGE/Akt/ERK Signaling Pathways | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Lee, Kwang-Won | - |
dc.identifier.doi | 10.1248/bpb.b21-00382 | - |
dc.identifier.scopusid | 2-s2.0-85120041191 | - |
dc.identifier.wosid | 000724969000015 | - |
dc.identifier.bibliographicCitation | BIOLOGICAL & PHARMACEUTICAL BULLETIN, v.44, no.11, pp.1697 - 1706 | - |
dc.relation.isPartOf | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.title | BIOLOGICAL & PHARMACEUTICAL BULLETIN | - |
dc.citation.volume | 44 | - |
dc.citation.number | 11 | - |
dc.citation.startPage | 1697 | - |
dc.citation.endPage | 1706 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.subject.keywordPlus | APOPTOSIS | - |
dc.subject.keywordPlus | CANCER | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | MIGRATION | - |
dc.subject.keywordPlus | ERK | - |
dc.subject.keywordPlus | AUTOPHAGY | - |
dc.subject.keywordPlus | RAGE | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordPlus | ENDPRODUCTS | - |
dc.subject.keywordPlus | MECHANISMS | - |
dc.subject.keywordAuthor | renal cell carcinoma | - |
dc.subject.keywordAuthor | proliferation | - |
dc.subject.keywordAuthor | apoptosis | - |
dc.subject.keywordAuthor | receptor for advanced glycation end product | - |
dc.subject.keywordAuthor | protein kinase B | - |
dc.subject.keywordAuthor | extracellular-signal-regulated kinase | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.